One-size-fits-all psychiatric care is being replaced by a more tailored approach, thanks to advancements in personalized psychiatry and precision medicine. By leveraging genetic data, biomarkers, neuroimaging, and digital phenotyping, clinicians can now better predict treatment responses, minimize adverse drug reactions, and select therapies aligned with a patient’s biological profile. This precision-driven model is particularly effective in complex disorders like bipolar depression, schizophrenia, and anxiety, where variability in symptoms and treatment outcomes has long challenged practitioners. Emerging pharmacogenetic tests and machine learning algorithms are accelerating diagnosis and guiding intervention. Personalized psychiatry is moving beyond theory into clinical reality, allowing more efficient, individualized, and enduring care pathways for mental health patients.
Title : Tailoring biblio-poetry therapies using AI and biofeedback for addiction treatment
Nile Stanley, University of North Florida, United States
Title : Clinical pharmacology of marijuana: Update 2024
Frederick J Goldstein, Philadelphia College of Osteopathic Medicine, United States
Title : Gangstalking is real, should be studied
Sam Vaknin, Southern Federal University, United Kingdom
Title : Decoding aggression, violence, and substance use in adolescents with conduct disorders: Neurochemical pathways and interventions
Ann Marie Leonard Zabel, Curry College, United States
Title : Sensoria driven genetic decoupling and impaired areal integration in diseases of agency
Denis Larrivee, University of Navarra, Spain
Title : Positive outcome of adherence to the reward deficiency syndrome solution system treatment plan: A longitudinal study
Elizabeth Dale Gilley, The Elle Foundation, United States